ASH HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSIONS: Ivosidenib with Venetoclax Azacitidine in IDH1-Mutated Hematologic Malignancies

ASH HIGHLIGHTS 2024 – LEUKEMIA ROUNDTABLE DISCUSSIONS: Ivosidenib with Venetoclax Azacitidine in IDH1-Mutated Hematologic Malignancies

ASH HIGHLIGHTS 2024 ROUNDTABLE DISCUSSIONS

Studies / Trials Discussed

Ivosidenib with Venetoclax Azacitidine in IDH1-Mutated Hematologic Malignancies

Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Julie Bergeron

Icon Chair Speaker

Speaker

Dr. Lynn Savoie

Dr. Brett Houston

Studies/trials discussed:

Ivosidenib with Venetoclax Azacitidine in IDH1-Mutated Hematologic Malignancies
Tagged